A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.
Public ClinicalTrials.gov record NCT05205252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ARIA: A Phase 1b/2, Open-label, Multi Cohort Trial of Tazemetostat in Combination With Various Treatments in Subjects With Relapsed or Refractory Hematologic Malignancies
Study identification
- NCT ID
- NCT05205252
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Epizyme, Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Interventions
- Tazemetostat Drug
- Tafasitamab Drug
- Lenalidomide Drug
- Acalabrutinib Drug
- Daratumumab (Intravenously) Drug
- Mosunetuzumab Drug
- Daratumumab (Subcutaneously) Drug
- Hyaluronidase-Fihj Drug
- Pomalidomide Drug
- Dexamethasone 20mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 21, 2021
- Primary completion
- Jul 4, 2023
- Completion
- Jul 4, 2023
- Last update posted
- Aug 14, 2023
2021 – 2023
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Associates For Research And Excellence, cCARE | Santa Fe | California | 92024 | — |
| Central Care Cancer Center | Bolivar | Missouri | 65613 | — |
| Astera Cancer Center | East Brunswick | New Jersey | 08816 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05205252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05205252 live on ClinicalTrials.gov.